SparingVision Conference Participation in H1 2021
SparingVision Conference Participation in H1 2021 SparingVision Conference Participation in H1 2021 Paris, February 16, 2021 - SparingVision ("the Company"), a genomic medicine company developing vision saving treatments for ocular diseases, announces the conferences that its management team will be participating in in the first half of 2021. OIS Gene Therapy Innovation Showcase , 18 February Gene Therapy Outlook panel, Prof. José Alain Sahel, scientific co-founder (2:30-3:30 PM EST) 4th Annual Gene Therapy for Rare Disorders , 22-25 February , Dr Dan Chung, Chief Medical Officer, (Feb 22, 3...
Source: finanznachrichten.de